Skip to main
LNSR

LENSAR Inc (LNSR) Stock Forecast & Price Target

LENSAR Inc (LNSR) Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

LENSAR is a commercial-stage medical device company that develops and markets an advanced femtosecond laser system for cataract treatment and management. With its proprietary technologies and focus on visual outcomes, efficiency, and precision, LENSAR is well-positioned for growth in the market. The company has a strong product portfolio and continues to see increasing adoption and utilization of its systems, which supports its recurring revenue stream. Despite facing challenges with the failed acquisition by Alcon (ALC), LENSAR has remained resilient and is poised for further growth with a diverse customer base and a growing market for femtosecond laser systems.

Bears say

LENSAR is a small-cap technology play on the fast-growing cataract surgery market, with a strong foothold in the laser segment and a unique offering in its ALLY system. Despite a steady cadence of revenue growth and above-peer CAGR, the company is currently trading at a significant discount to its ophthalmic peers, suggesting potential downside risks to our estimates and price target are likely due to slower uptake of ALLY, lower growth of FLACS, and higher operating expenditures.

LENSAR Inc (LNSR) has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of LENSAR Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About LENSAR Inc (LNSR) Forecast

Analysts have given LENSAR Inc (LNSR) a Strong Buy based on their latest research and market trends.

According to 1 analysts, LENSAR Inc (LNSR) has a Strong Buy consensus rating as of Aug 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

LENSAR Inc (LNSR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.